JP2022515838A5 - - Google Patents
Info
- Publication number
- JP2022515838A5 JP2022515838A5 JP2021537818A JP2021537818A JP2022515838A5 JP 2022515838 A5 JP2022515838 A5 JP 2022515838A5 JP 2021537818 A JP2021537818 A JP 2021537818A JP 2021537818 A JP2021537818 A JP 2021537818A JP 2022515838 A5 JP2022515838 A5 JP 2022515838A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- alox15
- acid molecule
- seq
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862785899P | 2018-12-28 | 2018-12-28 | |
| US62/785,899 | 2018-12-28 | ||
| PCT/US2019/068328 WO2020139830A2 (en) | 2018-12-28 | 2019-12-23 | Treatment of respiratory disorders with arachidonate15-lipoxygenase (alox15) inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022515838A JP2022515838A (ja) | 2022-02-22 |
| JP2022515838A5 true JP2022515838A5 (enExample) | 2022-12-13 |
Family
ID=69326713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021537818A Pending JP2022515838A (ja) | 2018-12-28 | 2019-12-23 | アラキドン酸１５－リポキシゲナーゼ（ａｌｏｘ１５）阻害剤による呼吸器障害の治療 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12472241B2 (enExample) |
| EP (1) | EP3902567A2 (enExample) |
| JP (1) | JP2022515838A (enExample) |
| KR (1) | KR20210110623A (enExample) |
| CN (1) | CN113423435A (enExample) |
| AU (1) | AU2019417718B2 (enExample) |
| CA (1) | CA3124670A1 (enExample) |
| IL (1) | IL284046A (enExample) |
| MX (1) | MX2021007938A (enExample) |
| NZ (1) | NZ777336A (enExample) |
| SG (1) | SG11202106517WA (enExample) |
| WO (1) | WO2020139830A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020150265A1 (en) | 2019-01-15 | 2020-07-23 | Empirico Inc. | Prodrugs of alox-15 inhibitors and methods of using the same |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5932425A (en) | 1997-02-18 | 1999-08-03 | Signal Pharmaceuticals, Inc. | Compositions and methods for modulating cellular NF-κB activation |
| FR2762841B1 (fr) | 1997-04-30 | 1999-07-02 | Jouveinal Inst Rech | Diazepino-indolones inhibitrices de phosphodiesterases iv |
| CA2268190A1 (en) | 1997-08-06 | 1999-02-18 | Suntory Limited | 1-aryl-1,8-naphthylidin-4-one derivative as type iv phosphodiesterase inhibitor |
| IT1296984B1 (it) | 1997-12-19 | 1999-08-03 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
| PL198983B1 (pl) | 1998-04-28 | 2008-08-29 | Elbion Ag | Nowe hydroksyindole, ich zastosowanie jako inhibitorów fosfodiesterazy 4 oraz sposoby ich wytwarzania |
| PT1086096E (pt) | 1998-06-10 | 2003-12-31 | Altana Pharma Ag | Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4 |
| IT1302677B1 (it) | 1998-10-15 | 2000-09-29 | Zambon Spa | Derivati benzazinici inibitori della fosfodiesterasi 4 |
| IT1303272B1 (it) | 1998-10-29 | 2000-11-06 | Zambon Spa | Derivati triciclici inibitori della fosfodiesterasi 4 |
| US6686502B1 (en) * | 1999-03-26 | 2004-02-03 | Ucb S.A. | Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| US6740666B2 (en) | 2000-12-20 | 2004-05-25 | Merck & Co., Inc. | Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| CA2447765C (en) | 2001-05-24 | 2011-01-25 | Merck Frosst Canada & Co./Merck Frosst Canada & Cie | 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors |
| JO2311B1 (en) | 2001-08-29 | 2005-09-12 | ميرك فروست كندا ليمتد | Alkyl inhibitors Ariel phosphodiesterase-4 |
| AR037517A1 (es) | 2001-11-05 | 2004-11-17 | Novartis Ag | Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria |
| IS7839A (is) | 2002-11-22 | 2004-05-23 | Merck Frosst Canada Ltd. | 4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar |
| MY141255A (en) | 2003-12-11 | 2010-03-31 | Memory Pharm Corp | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
| CA2844775A1 (en) * | 2011-08-23 | 2013-02-28 | Cornerstone Therapeutics Inc. | Use of zileuton for the treatment of nasal polyps in cystic fibrosis patients |
| US10132809B2 (en) | 2012-10-10 | 2018-11-20 | Rhote Island Hospital | Differential expression of protein markers for the diagnosis and treatment of eosinophilic esophagitis |
| CN111437387B (zh) | 2013-06-21 | 2024-10-01 | 赛诺菲生物技术公司 | 通过施用il-4r拮抗剂治疗鼻息肉症的方法 |
| EP3735248A4 (en) * | 2018-02-09 | 2021-11-17 | Empirico Inc. | PROCESS FOR INHIBITED OR ELIMINATING EOSINOPHILIC DISEASES OF THE RESPIRATORY TRACT AND ASSOCIATED CONDITIONS |
-
2019
- 2019-12-23 WO PCT/US2019/068328 patent/WO2020139830A2/en not_active Ceased
- 2019-12-23 AU AU2019417718A patent/AU2019417718B2/en active Active
- 2019-12-23 MX MX2021007938A patent/MX2021007938A/es unknown
- 2019-12-23 US US16/725,309 patent/US12472241B2/en active Active
- 2019-12-23 CA CA3124670A patent/CA3124670A1/en active Pending
- 2019-12-23 KR KR1020217023172A patent/KR20210110623A/ko active Pending
- 2019-12-23 NZ NZ777336A patent/NZ777336A/en unknown
- 2019-12-23 JP JP2021537818A patent/JP2022515838A/ja active Pending
- 2019-12-23 EP EP19843006.8A patent/EP3902567A2/en active Pending
- 2019-12-23 CN CN201980090028.XA patent/CN113423435A/zh active Pending
- 2019-12-23 SG SG11202106517WA patent/SG11202106517WA/en unknown
-
2021
- 2021-06-15 IL IL284046A patent/IL284046A/en unknown
-
2025
- 2025-10-21 US US19/364,245 patent/US20260097102A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022523301A5 (enExample) | ||
| JP2006500949A5 (enExample) | ||
| JP2008520242A5 (enExample) | ||
| CN1932041B (zh) | 对于赤鹿、梅花鹿、马鹿以及驯鹿的基因特异的引物以及利用该引物识别鹿茸品种的方法 | |
| KR102029775B1 (ko) | 비근침윤성 방광암 진단용 바이오마커 및 이의 용도 | |
| WO2008109773A2 (en) | Chronic obstructive pulmonary disease susceptibility and related compositions and methods | |
| KR20170015509A (ko) | 담도암 검출 키트 또는 디바이스 및 검출 방법 | |
| JP6619332B2 (ja) | ヒトｅｚｈ２遺伝子中の変異を検出するための方法及び組成物 | |
| JP2023531935A5 (enExample) | ||
| JP2016533708A5 (enExample) | ||
| JP2008512984A5 (enExample) | ||
| JP2005537007A5 (enExample) | ||
| JP2022515838A5 (enExample) | ||
| JP2008545390A (ja) | 遺伝的多型を用いた肺癌を発達させるリスクの評価方法 | |
| JP2022525545A5 (enExample) | ||
| JP2022525456A5 (enExample) | ||
| JP2022525546A5 (enExample) | ||
| KR101683086B1 (ko) | 유전자의 발현량 및 메틸화 프로필을 활용한 돼지의 산자수 예측방법 | |
| CN108676852B (zh) | 在外周血游离dna中检测p53基因表观遗传学修饰差异的引物对组及试剂盒 | |
| RU2023131494A (ru) | Лечение цереброваскулярного заболевания с помощью агентов - белков-гомологов 3 нейрогенного локуса notch (notch3) | |
| KR101735762B1 (ko) | 유전자의 발현프로필을 이용한 돼지의 산자수 예측방법 | |
| RU2021122161A (ru) | Лечение респираторных нарушений с помощью ингибиторов арахидонат 15-липоксигеназы (alox15) | |
| RU2021121850A (ru) | Лечение офтальмологических патологических состояний ингибиторами ангиопоэтин-подобного белка 7 (angptl7) | |
| JP2024536001A5 (enExample) | ||
| CN112226528B (zh) | 一种用于生物组织样本检测细菌污染的质检方法 |